Elevance Health, Inc.

NYSE:ELV 株式レポート

時価総額:US$124.3b

このページの翻訳は実験的なもので、現在開発中です。お待ちしております!

Elevance Health 配当金

配当金 基準チェック /46

Elevance Health配当を支払う会社であり、現在の利回りは1.24%で、収益によって十分にカバーされています。

主要情報

1.2%

配当利回り

23%

配当性向

業界平均利回り1.8%
次回配当支払日n/a
配当落ち日n/a
一株当たり配当金n/a
一株当たり利益US$26.87
3年後の配当利回り予想1.4%

最近の配当金アップデート

Elevance Health (NYSE:ELV) Has Announced A Dividend Of $1.63

Apr 25
Elevance Health (NYSE:ELV) Has Announced A Dividend Of $1.63

Elevance Health (NYSE:ELV) Will Pay A Larger Dividend Than Last Year At $1.63

Feb 19
Elevance Health (NYSE:ELV) Will Pay A Larger Dividend Than Last Year At $1.63

Recent updates

Is Now An Opportune Moment To Examine Elevance Health, Inc. (NYSE:ELV)?

Jun 11
Is Now An Opportune Moment To Examine Elevance Health, Inc. (NYSE:ELV)?

Elevance Health's (NYSE:ELV) Returns On Capital Are Heading Higher

May 27
Elevance Health's (NYSE:ELV) Returns On Capital Are Heading Higher

We Think Shareholders Will Probably Be Generous With Elevance Health, Inc.'s (NYSE:ELV) CEO Compensation

May 09
We Think Shareholders Will Probably Be Generous With Elevance Health, Inc.'s (NYSE:ELV) CEO Compensation

Elevance Health (NYSE:ELV) Has Announced A Dividend Of $1.63

Apr 25
Elevance Health (NYSE:ELV) Has Announced A Dividend Of $1.63

Elevance Health: It's Not Too Late To Buy Their Dividend Growth

Apr 23

Is Elevance Health (NYSE:ELV) Using Too Much Debt?

Apr 16
Is Elevance Health (NYSE:ELV) Using Too Much Debt?

Elevance Health: Not Doing Enough In 2024 To Justify Premium Price

Apr 11

Elevance Health, Inc.'s (NYSE:ELV) Earnings Haven't Escaped The Attention Of Investors

Apr 01
Elevance Health, Inc.'s (NYSE:ELV) Earnings Haven't Escaped The Attention Of Investors

Elevance: A Healthy Dose Of Dividend Growth

Mar 21

Elevance Heath: Financial Growth And Technical Strength Indicate A Buy

Mar 07

Elevance Health (NYSE:ELV) Will Pay A Larger Dividend Than Last Year At $1.63

Feb 19
Elevance Health (NYSE:ELV) Will Pay A Larger Dividend Than Last Year At $1.63

Elevance Health: Time To Buy This Incredible Dividend Growth Stock

Jan 26

Slowing Rates Of Return At Elevance Health (NYSE:ELV) Leave Little Room For Excitement

Jan 19
Slowing Rates Of Return At Elevance Health (NYSE:ELV) Leave Little Room For Excitement

Is Elevance Health (NYSE:ELV) A Risky Investment?

Jan 02
Is Elevance Health (NYSE:ELV) A Risky Investment?

Elevance Health, Inc.'s (NYSE:ELV) Shares Not Telling The Full Story

Dec 18
Elevance Health, Inc.'s (NYSE:ELV) Shares Not Telling The Full Story

A Look At Elevance's Margin Dynamics

Nov 23

Is It Time To Consider Buying Elevance Health, Inc. (NYSE:ELV)?

Nov 16
Is It Time To Consider Buying Elevance Health, Inc. (NYSE:ELV)?

Elevance Health: A High Conviction Defensive Blue Chip Buy

Oct 19

These 4 Measures Indicate That Elevance Health (NYSE:ELV) Is Using Debt Safely

Oct 04
These 4 Measures Indicate That Elevance Health (NYSE:ELV) Is Using Debt Safely

Elevance: Pave The Way For The Next UnitedHealth

Sep 21

Elevance Health (NYSE:ELV) Is Experiencing Growth In Returns On Capital

Sep 18
Elevance Health (NYSE:ELV) Is Experiencing Growth In Returns On Capital

Here's The Price I Would Buy Elevance Health Stock

Sep 13

If EPS Growth Is Important To You, Elevance Health (NYSE:ELV) Presents An Opportunity

Aug 18
If EPS Growth Is Important To You, Elevance Health (NYSE:ELV) Presents An Opportunity

Is Now The Time To Look At Buying Elevance Health, Inc. (NYSE:ELV)?

Aug 04
Is Now The Time To Look At Buying Elevance Health, Inc. (NYSE:ELV)?

Narrowing Down High-Quality Dividend Growth: Elevance Health Is Elemental

Jul 24

Elevance Health: Beaten Down Share Price Offers Solid Potential

Jul 10

Here's Why Elevance Health (NYSE:ELV) Can Manage Its Debt Responsibly

Jul 05
Here's Why Elevance Health (NYSE:ELV) Can Manage Its Debt Responsibly

Elevance Health: A Critical Update (Rating Downgrade)

Jun 05

Elevance Health's (NYSE:ELV) Returns On Capital Are Heading Higher

Jun 04
Elevance Health's (NYSE:ELV) Returns On Capital Are Heading Higher

Is Now The Time To Look At Buying Elevance Health, Inc. (NYSE:ELV)?

May 05
Is Now The Time To Look At Buying Elevance Health, Inc. (NYSE:ELV)?

We Think Elevance Health (NYSE:ELV) Can Stay On Top Of Its Debt

Apr 04
We Think Elevance Health (NYSE:ELV) Can Stay On Top Of Its Debt

Elevance Health's (NYSE:ELV) Dividend Will Be Increased To $1.48

Feb 17
Elevance Health's (NYSE:ELV) Dividend Will Be Increased To $1.48

Elevance Health (NYSE:ELV) Is Experiencing Growth In Returns On Capital

Feb 13
Elevance Health (NYSE:ELV) Is Experiencing Growth In Returns On Capital

Elevance Health: Attractive On Its Expansion Catalysts

Feb 09

Elevance Health (NYSE:ELV) Has Announced That It Will Be Increasing Its Dividend To $1.48

Jan 28
Elevance Health (NYSE:ELV) Has Announced That It Will Be Increasing Its Dividend To $1.48

Elevance Health acquiring Blue Cross and Blue Shield of Louisiana

Jan 23

Elevance Health Offers Great Value

Jan 17

At US$483, Is Elevance Health Inc. (NYSE:ELV) Worth Looking At Closely?

Jan 17
At US$483, Is Elevance Health Inc. (NYSE:ELV) Worth Looking At Closely?

Elevance Health: Strong And Steady EPS Growth Ahead, High Relative Strength Name

Jan 02

Elevance Health (NYSE:ELV) Seems To Use Debt Rather Sparingly

Nov 28
Elevance Health (NYSE:ELV) Seems To Use Debt Rather Sparingly

Does Elevance Health (NYSE:ELV) Deserve A Spot On Your Watchlist?

Nov 16
Does Elevance Health (NYSE:ELV) Deserve A Spot On Your Watchlist?

Elevance Health to acquire speciality pharmacy from CarepathRx

Nov 09

Elevance Health (NYSE:ELV) Is Doing The Right Things To Multiply Its Share Price

Nov 02
Elevance Health (NYSE:ELV) Is Doing The Right Things To Multiply Its Share Price

Elevance Health declares $1.28 dividend

Oct 19

Are Investors Undervaluing Elevance Health Inc. (NYSE:ELV) By 37%?

Oct 12
Are Investors Undervaluing Elevance Health Inc. (NYSE:ELV) By 37%?

Elevance affiliates to offer affordable Medicare Advantage plans

Oct 10

Molina, Elevance, Centene win Medicare contracts in California

Aug 26

決済の安定と成長

配当データの取得

安定した配当: ELVの1株当たり配当金は過去10年間安定しています。

増加する配当: ELVの配当金は過去10年間にわたって増加しています。


配当利回り対市場

Elevance Health 配当利回り対市場
ELV 配当利回りは市場と比べてどうか?
セグメント配当利回り
会社 (ELV)1.2%
市場下位25% (US)1.5%
市場トップ25% (US)4.8%
業界平均 (Healthcare)1.8%
3年後のアナリスト予想 (ELV)1.4%

注目すべき配当: ELVの配当金 ( 1.24% ) はUS市場の配当金支払者の下位 25% ( 1.53% ) と比べると目立ったものではありません。

高配当: ELVの配当金 ( 1.24% ) はUS市場の配当金支払者の上位 25% ( 4.81% ) と比較すると低いです。


株主への利益配当

収益カバレッジ: ELVは低い 配当性向 ( 22.8% ) であるため、配当金の支払いは利益によって十分にカバーされます。


株主配当金

キャッシュフローカバレッジ: ELVは合理的な 現金配当性向 ( 66% ) を備えているため、配当金の支払いはキャッシュフローによって賄われます。


高配当企業の発掘